nicardipine has been researched along with Leukoaraiosis in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Leukoaraiosis: Non-specific white matter changes in the BRAIN, often seen after age 65. Changes include loss of AXONS; MYELIN pallor, GLIOSIS, loss of ependymal cells, and enlarged perivascular spaces. Leukoaraiosis is a risk factor for DEMENTIA and CEREBROVASCULAR DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morotti, A | 1 |
| Shoamanesh, A | 1 |
| Oliveira-Filho, J | 1 |
| Schlunk, F | 1 |
| Romero, JM | 1 |
| Jessel, M | 1 |
| Ayres, A | 1 |
| Vashkevich, A | 1 |
| Schwab, K | 1 |
| Cassarly, C | 1 |
| Martin, RH | 1 |
| Greenberg, SM | 1 |
| Qureshi, AI | 1 |
| Rosand, J | 1 |
| Goldstein, JN | 1 |
1 trial available for nicardipine and Leukoaraiosis
| Article | Year |
|---|---|
White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
Topics: Adult; Aged; Antihypertensive Agents; Case-Control Studies; Cerebral Hemorrhage; Disease Progression | 2020 |